Sachio Nohara

Amagasaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Transcriptome Concordance Between Borderline Tumors and Endometrioid Carcinoma: An Integrative Genomic Analysis.

Transcriptome Concordance Between Borderline Tumors and Endometrioid Carcinoma: An Integrative Genomic Analysis.

Journal: Cancer medicine

Published: November 26, 2024

Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan.

Clinical and Diagnostic Utility of Genomic Profiling for Digestive Cancers: Real-World Evidence from Japan.

Journal: Cancers

Published: March 18, 2024

Characterizing multi-PIK3CA mutations across cancer types: Toward precision oncology.

Characterizing multi-PIK3CA mutations across cancer types: Toward precision oncology.

Journal: Cancer medicine

Published: March 12, 2024

BRCA1/2 reversion mutations in a pan-cancer cohort.

BRCA1/2 reversion mutations in a pan-cancer cohort.

Journal: Cancer science

Published: September 13, 2023

Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer.

Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer.

Journal: Cancer medicine

Published: December 05, 2022

Clinical predominance of whole-exome sequencing to evaluate microsatellite instability status.

Clinical predominance of whole-exome sequencing to evaluate microsatellite instability status.

Journal: Cancer science

Published: November 05, 2022

ATM immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma.

ATM immunohistochemistry as a potential marker for the differential diagnosis of no specific molecular profile subtype and POLE-mutation subtype endometrioid carcinoma.

Journal: Pathology, research and practice

Published: October 09, 2021

Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.

Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.

Journal: Pathology oncology research : POR

Published: August 06, 2021

Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.

Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.

Journal: Cancer medicine

Published: April 28, 2020

Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.

Next-generation sequencing analysis of endometrial screening liquid-based cytology specimens: a comparative study to tissue specimens.

Journal: BMC medical genomics

Published: March 24, 2020

MGeND: an integrated database for Japanese clinical and genomic information.

MGeND: an integrated database for Japanese clinical and genomic information.

Journal: Human genome variation

Published: April 08, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026